1. Conditional relative survival in Waldenström’s macroglobulinaemia
- Author
-
Marie José Kersten, Avinash G. Dinmohamed, Eduardus F. M. Posthuma, Monique C. Minnema, Josephine M.I. Vos, Karima Amaador, Otto Visser, Graduate School, Clinical Haematology, CCA - Cancer biology and immunology, CCA - Cancer Treatment and Quality of Life, and Public Health
- Subjects
Male ,Risk ,Pediatrics ,medicine.medical_specialty ,Population ,Disease ,Lymphoplasmacytic Lymphoma ,Disease course ,Refractory ,Humans ,Medicine ,education ,Aged ,Netherlands ,Aged, 80 and over ,education.field_of_study ,Relative survival ,business.industry ,Treatment options ,Hematology ,Middle Aged ,Survival Analysis ,population-based ,Population based study ,Waldenström’s macroglobulinaemia ,conditional relative survival ,lymphoplasmacytic lymphoma ,Female ,Waldenstrom Macroglobulinemia ,business - Abstract
Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nature of this disease characterized by multiple relapses throughout the disease course with limited efficacious treatment options in the released/refractory setting.
- Published
- 2021